Ottawa, April 25, 2013 — From May 5th to 7th, 2013, more than 400 people from six countries and three continents will converge on St. John’s, Newfoundland and Labrador, to talk about how evidence can best be used to make health care decisions.
“It is a testament to Newfoundland and Labrador’s commitment to the value of evidence-based health care that Susan Sullivan, Minister of Health and Community Services, will open this important national symposium,” says Dr. Brian O’Rourke, President and CEO of the Canadian Agency for Drugs and Technologies in Health (CADTH).
The province’s health policy- and decision-makers, as well Canadian and international scientists, economists, and health care professionals, will participate in discussions on how evidence-based information on drugs, health care devices, and procedures can be used to help inform decisions in publicly funded health care systems.
Deputy Minister of Health Bruce Cooper will speak during the welcome reception. He and the Honourable Ms. Sullivan will be joined by health care leaders and administrators from Newfoundland and Labrador and other provinces and territories of Canada, as well as speakers from 24 Canadian and international research institutions that include representation from the United States and United Kingdom, Australia, Switzerland, and France.
Workshops and forums on a wide variety of topics include:
- Public consultation on pharmaceutical policy
- Transparency in the drug funding process
- Drug pricing
- Big ideas for health technology assessment.
Other sessions will address the optimal use of health technologies in the delivery of health care to rural and remote communities — a topic your viewers/listeners will certainly be interested in.
CADTH hosts its annual symposium in various Canadian cities. The pan-Canadian agency delivers evidence-based information to health care leaders, and to decision- and policy-makers. CADTH’s relevant and timely products and services — including advice, recommendations, and tools — help decision-makers achieve value for money and outstanding health outcomes. With a Liaison Officer permanently based in St. John’s, CADTH brings world-class evidence closer to home.
For more information or for an interview with CADTH’s President and CEO, Dr. Brian O’Rourke, please contact:
- Janis Bogart, Communications Officer (613) 226-2553 email@example.com
- 2013 CADTH Symposium: Evidence in Context
- May 5 to 7, 2013
- Delta St. John’s Hotel and Conference Centre
- St. John’s, Newfoundland and Labrador
Download Guidebook on the Apple App Store or Google Play or visit guidebook.com/getit.
May 5 to 7, 2013
Delta St. John’s Hotel and Conference Centre
St. John’s, Newfoundland
Evidence in Context
Health technology assessment (HTA) delivers scientifically rigorous information to support effective technology management. But clinical and cost-effectiveness evidence may not be enough to ensure an impact in today’s complex and constantly evolving health care environment. Decision-makers also need to consider the context in which decisions are made, and a wide range of social, political, and value-based factors that will influence how the evidence is interpreted and applied.
What impact does context have on the type of evidence required and how is it used? How much contextualization is really necessary? How are HTA providers and decision-makers in Canada and other countries approaching contextualization, and are these approaches increasing the impact of HTA?
Join Canadian and international experts at the 2013 CADTH Symposium for thought- provoking discussions about the role of evidence, context, and other factors that are integral to the optimal use of health technologies.